The global RNA-based therapies market, valued at US$ 90.56 billion in 2024, is projected to reach US$ 213.54 billion by 2033, driven by advances in mRNA, ASO and RNAi therapeutics. https://finance.yahoo.com/news/rna-based-therapies-market-reach-151600770.html